Recovia I 17 and Northern Avenue
-
Services:
- Cognitive behavioral therapy
- Motivational interviewing
- Substance use disorder counseling
- Trauma-related counseling
- Relapse prevention
- Telemedicine/telehealth therapy
- Opioids detoxification
- Medication routinely used during detoxification
- Outpatient detoxification
- Outpatient
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Intensive outpatient treatment
- Outpatient day treatment or partial hospitalization
- Naloxone and overdose education
- Aftercare/continuing care
- Outcome follow-up after discharge
- Smoking permitted in designated area
- Female
- Male
- Screening for tobacco use
- Comprehensive substance use assessment
- Screening for mental disorders
- Comprehensive mental health assessment
- Screening for substance use
- Private for-profit organization
- State department of health
- Clients with co-occurring pain and substance use disorders
- Clients with co-occurring mental and substance use disorders
- Clients who have experienced trauma
- No formal relationship with prescribing entity
- Mental health services
- Social skills development
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Adults
- Young Adults
- Relapse prevention with naltrexone
- Prescribes naltrexone
- Buprenorphine maintenance
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes buprenorphine
- Buprenorphine detoxification
- Individual counseling
- Group counseling
- Substance use disorder education
- Medicaid
- Cash or self-payment
- State-financed health insurance plan other than Medicaid
- Medicare
- Private health insurance
- Federal military insurance (e.g., TRICARE)
- This facility administers/prescribes medication for alcohol use disorder
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- Mentoring/peer support
- Detoxification
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Vaping permitted in designated area
- Buprenorphine with naloxone
- Naltrexone (oral)
- Buprenorphine without naloxone
- Clonidine
- Buprenorphine (extended-release, injectable)
- Medication for mental disorders
- Naltrexone (extended-release, injectable)
- Acamprosate (Campral®)
Treatment Approaches
Detoxification (medical withdrawal) Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Transitional Services
Facility Smoking Policy
Gender Accepted
Assessment/Pre-treatment
Facility Operation (e.g., Private, Public)
License/Certification/Accreditation
Special Programs/Groups Offered
External Source of Medications Used for Alcohol Use Disorder Treatment
Ancillary Services
Opioid Medications used in Treatment
Age Groups Accepted
Type of Opioid Treatment
Education and Counseling Services
Payment/Insurance/Funding Accepted
Type of Alcohol Use Disorder Treatment
Testing
Recovery Support Services
Type of Care
Facility Vaping Policy
Pharmacotherapies